US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary Market Research Reports & Industry Analysis

RSS Feeds

Respiratory/Pulmonary Industry Research & Market Reports

1    3    5  6  7  8  9  10  
2015 Opportunities in the French Respiratory Diseases Diagnostic Testing Market
4/22/2015 | published by: VPGMarketResearch.com
... for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report:- Examines market ...  |  read more...
USD 1,950
2015 Opportunities in the European Respiratory Diseases Diagnostic Testing Market
4/22/2015 | published by: VPGMarketResearch.com
... market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific views on epidemiology and etiology ...  |  read more...
USD 8,300
2015 Opportunities in the US Respiratory Diseases Diagnostic Testing Market
4/22/2015 | published by: VPGMarketResearch.com
... for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to market share and sales forecasts, ...  |  read more...
USD 3,600
Emphysema-API Insights, 2015
4/21/2015 | published by: DelveInsight
... Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Emphysema. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s ...  |  read more...
USD 1,250
Acute Bronchitis-API Insights, 2015
4/21/2015 | published by: DelveInsight
... the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Acute Bronchitis. The Report provides the India and China API Manufactures who are driving the ...  |  read more...
USD 1,250
Bronchitis-API Insights, 2015
4/21/2015 | published by: DelveInsight
... Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Bronchitis. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s ...  |  read more...
USD 1,250
Chronic Bronchitis-API Insights, 2015
4/21/2015 | published by: DelveInsight
... the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Chronic Bronchitis. The Report provides the India and China API Manufactures who are driving the ...  |  read more...
USD 1,250
Lower Respiratory Tract Infections-API Insights, 2015
4/21/2015 | published by: DelveInsight
... report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Lower Respiratory Tract Infections. The Report provides the India ...  |  read more...
USD 1,250
Bronchitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Bronchitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Bronchitis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Chronic Bronchitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Chronic Bronchitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Chronic Bronchitis- Pipeline ...  |  read more...
USD 1,250
Cough-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Cough Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Cough- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Emphysema-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Emphysema Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Emphysema- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Lung Infections-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Lung Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Lung Infections- Pipeline ...  |  read more...
USD 1,250
Lung Injury-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Lung Injury Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Lung Injury- Pipeline ...  |  read more...
USD 1,250
Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease ...  |  read more...
USD 1,250
Pulmonary Arterial Hypertension-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Pulmonary Arterial Hypertension Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Pulmonary Hypertension-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Pulmonary Hypertension Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Pulmonary Hypertension- Pipeline ...  |  read more...
USD 1,250
Respiratory Depression-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Respiratory Depression Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Respiratory Depression- Pipeline ...  |  read more...
USD 1,250
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Syndrome (SARS) Coronavirus Infection. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Report helps to ...  |  read more...
USD 1,250
Pulmonary Hypertension-API Insights, 2015
4/21/2015 | published by: DelveInsight
... the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Pulmonary Hypertension. The Report provides the India and China API Manufactures who are driving the ...  |  read more...
USD 1,250
Pulmonary Arterial Hypertension-API Insights, 2015
4/21/2015 | published by: DelveInsight
... clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Pulmonary Arterial Hypertension. The Report provides the India and China API Manufactures ...  |  read more...
USD 1,250
Chronic Obstructive Pulmonary Disorder (COPD): KOL Insight
4/15/2015 | published by: FirstWord
... market position and share. But will clinicians, payers and patients be persuaded to change from well-established products? Despite recently approved dual combinations of Long Acting Muscarinic Antagonists (LAMA) and Long Acting Beta2 Agonists (LABA) bringing ...  |  read more...
USD 7,495
2015 U.S. Patient care - Respiratory system sold through Offices of physicians-Product & Services Report
5/15/2015 | published by: Barnes Reports
... report features 2015 current and 2016 forecast estimates on the sales of Patient care - Respiratory system sold through Offices of physicians nationally and for all 50 U.S. States and up to 900 metro areas.  |  read more...
USD 199
2015 U.S. Patient care - Respiratory system sold through Medical & surgical hospitals-Product & Services Report
5/15/2015 | published by: Barnes Reports
... features 2015 current and 2016 forecast estimates on the sales of Patient care - Respiratory system sold through Medical & surgical hospitals nationally and for all 50 U.S. States and up to 900 metro areas. ...  |  read more...
USD 199
Market Assessment of Respiratory Diagnostics in the United States and Europe
5/18/2015 | published by: Frost & Sullivan
... total CT scan procedures. oA CT scan is recommended for smokers over the age of ?? (approximately ?? million of the total ?? million smokers), and ?? million CT scans have been performed on people ...  |  read more...
USD 1,500
1    3    5  6  7  8  9  10